Nathan Wolfe

Last updated
Nathan D. Wolfe
Nathan Wolfe 2011 Shankbone.JPG
Wolfe in 2011
Born (1970-08-24) August 24, 1970 (age 53)
CitizenshipUnited States
Alma materStanford, Harvard
Scientific career
Fields Virology
Institutions Stanford, UCLA

Nathan Daniel Wolfe (born 24 August 1970) is an American virologist. He was the founder (in 2007) and director of Global Viral [1] and the Lorry I. Lokey Visiting Professor in Human Biology at Stanford University.

Contents

Career

Wolfe spent over eight years conducting biomedical research in both sub-Saharan Africa and Southeast Asia. He is also the founder of Metabiota, which offers both governmental and corporate services for biological threat evaluation and management. He serves on the editorial board of EcoHealth and Scientific American and is a member of DARPA's Defense Science Research Council. His laboratory was among the first to discover and describe the Simian foamy virus. [2]

In 2008, he warned that the world was not ready for a pandemic. [3]

In 2011, his book The Viral Storm: The Dawn of a New Pandemic Age [4] was short-listed for the Winton Prize. [5]

As reported in a Wired feature in 2020, Wolfe worked with the German insurance firm Munich Re to offer major corporate leaders pandemic policies, which were not purchased; a stark reality during the ensuing COVID-19 pandemic. [6]

Awards

Wolfe has been awarded more than $40 million in funding from a diverse array of sources including the U.S. Department of Defense, Google.org, the National Institutes of Health, the Skoll Foundation, the Bill & Melinda Gates Foundation and the National Geographic Society. [7]

Personal life

Wolfe is married to the playwright Lauren Gunderson and has 2 sons. As part of his work, he has lived in Cameroon, Malaysia and Uganda. [5]

Related Research Articles

<span class="mw-page-title-main">Zoonosis</span> Disease that can be transmitted from other species to humans

A zoonosis or zoonotic disease is an infectious disease of humans caused by a pathogen that can jump from a non-human to a human and vice versa.

<span class="mw-page-title-main">Epidemic</span> Rapid spread of disease affecting a large number of people in a short time

An epidemic is the rapid spread of disease to a large number of hosts in a given population within a short period of time. For example, in meningococcal infections, an attack rate in excess of 15 cases per 100,000 people for two consecutive weeks is considered an epidemic.

<span class="mw-page-title-main">Emerging infectious disease</span> Infectious disease of emerging pathogen, often novel in its outbreak range or transmission mode

An emerging infectious disease (EID) is an infectious disease whose incidence has increased recently, and could increase in the near future. The minority that are capable of developing efficient transmission between humans can become major public and global concerns as potential causes of epidemics or pandemics. Their many impacts can be economic and societal, as well as clinical. EIDs have been increasing steadily since at least 1940.

An emergent virus is a virus that is either newly appeared, notably increasing in incidence/geographic range or has the potential to increase in the near future. Emergent viruses are a leading cause of emerging infectious diseases and raise public health challenges globally, given their potential to cause outbreaks of disease which can lead to epidemics and pandemics. As well as causing disease, emergent viruses can also have severe economic implications. Recent examples include the SARS-related coronaviruses, which have caused the 2002-2004 outbreak of SARS (SARS-CoV-1) and the 2019–21 pandemic of COVID-19 (SARS-CoV-2). Other examples include the human immunodeficiency virus which causes HIV/AIDS; the viruses responsible for Ebola; the H5N1 influenza virus responsible for avian flu; and H1N1/09, which caused the 2009 swine flu pandemic. Viral emergence in humans is often a consequence of zoonosis, which involves a cross-species jump of a viral disease into humans from other animals. As zoonotic viruses exist in animal reservoirs, they are much more difficult to eradicate and can therefore establish persistent infections in human populations.

Globalization, the flow of information, goods, capital, and people across political and geographic boundaries, allows infectious diseases to rapidly spread around the world, while also allowing the alleviation of factors such as hunger and poverty, which are key determinants of global health. The spread of diseases across wide geographic scales has increased through history. Early diseases that spread from Asia to Europe were bubonic plague, influenza of various types, and similar infectious diseases.

<span class="mw-page-title-main">Skoll Foundation</span> US philanthropic foundation

The Skoll Foundation is a private foundation based in Palo Alto, California. The foundation makes grants and investments intended to reduce global poverty. Jeffrey Skoll created the foundation in 1999.

Devex is a social enterprise and media platform for the global development community. It aims to connect with and inform development, health, humanitarian, and sustainability professionals through news, business intelligence, funding and career opportunities related to international development. As an independent news organization, Devex employs more than 100 staff members in different locations, including Washington, D.C., where the organization is headquartered. It also maintains offices in Barcelona and Manila.

<span class="mw-page-title-main">W. Ian Lipkin</span> Professor, microbiologist, epidemiologist

Walter Ian Lipkin is the John Snow Professor of Epidemiology at the Mailman School of Public Health at Columbia University and a professor of Neurology and Pathology at the College of Physicians and Surgeons at Columbia University. He is also director of the Center for Infection and Immunity, an academic laboratory for microbe hunting in acute and chronic diseases. Lipkin is internationally recognized for his work with West Nile virus, SARS and COVID-19.

<span class="mw-page-title-main">Robert M. Wachter</span> American physician

Robert M. "Bob" Wachter is an academic physician and author. He is on the faculty of University of California, San Francisco, where he is chairman of the Department of Medicine, the Lynne and Marc Benioff Endowed Chair in Hospital Medicine, and the Holly Smith Distinguished Professor in Science and Medicine. He is generally regarded as the academic leader of the hospitalist movement, the fastest growing specialty in the history of modern medicine. He and a colleague, Lee Goldman, are known for coining the term "hospitalist" in a 1996 New England Journal of Medicine article.

Global Viral (GV), previously known as Global Viral Forecasting Institute (GVFI), is a 501(c)(3) not-for-profit organization based in San Francisco, California. It was founded in 2007 by Nathan Wolfe to study infectious diseases, their transmission between animals and humans, and the risk involved with their global spread. An original goal of the organization was to develop an early warning system for pandemics and at one point Global Viral coordinated a staff of over 100 scientists in China, Cameroon, Equatorial Guinea, DR Congo, Republic of the Congo, Laos, Gabon, Central African Republic, Malaysia, Madagascar and Sao Tome.

<span class="mw-page-title-main">Robert Shope</span> American virologist and epidemiologist

Robert Ellis Shope was an American virologist, epidemiologist and public health expert, particularly known for his work on arthropod-borne viruses and emerging infectious diseases. He discovered more novel viruses than any person previously, including members of the Arenavirus, Hantavirus, Lyssavirus and Orbivirus genera of RNA viruses. He researched significant human diseases, including dengue, Lassa fever, Rift Valley fever, yellow fever, viral hemorrhagic fevers and Lyme disease. He had an encyclopedic knowledge of viruses, and curated a global reference collection of over 5,000 viral strains. He was the lead author of a groundbreaking report on the threat posed by emerging infectious diseases, and also advised on climate change and bioterrorism.

Guan Yi is a Chinese virologist. In 2014, he was ranked as 11th in the world by Thomson Reuters among global researchers in the field of microbiology. He obtained his PhD in microbiology at the University of Hong Kong and is now a professor of microbiology at his alma mater. His research on the viral respiratory disease SARS helped the Chinese government avert the 2004 outbreak of this disease. He is the current director of the State Key Laboratory for Emerging Infectious Diseases University of Hong Kong. In early 2017, Guan warned that the H7N9 influenza virus "poses the greatest threat to humanity than any other in the past 100 years".

<span class="mw-page-title-main">Disease X</span> Placeholder infectious disease name from the WHO

Disease X is a placeholder name that was adopted by the World Health Organization (WHO) in February 2018 on their shortlist of blueprint priority diseases to represent a hypothetical, unknown pathogen that could cause a future epidemic. The WHO adopted the placeholder name to ensure that their planning was sufficiently flexible to adapt to an unknown pathogen. Director of the US National Institute of Allergy and Infectious Diseases Anthony Fauci stated that the concept of Disease X would encourage WHO projects to focus their research efforts on entire classes of viruses, instead of just individual strains, thus improving WHO capability to respond to unforeseen strains. In 2020, experts, including some of the WHO's own expert advisors, speculated that COVID-19, caused by the SARS-CoV-2 virus strain, met the requirements to be the first Disease X.

Daniel R. Lucey is an American physician, researcher, senior scholar and adjunct professor of infectious diseases at Georgetown University, and a research associate in anthropology at the Smithsonian National Museum of Natural History, where he has co-organised an exhibition on eight viral outbreaks.

<span class="mw-page-title-main">Christian Drosten</span> German virologist researching emergent viruses

Christian Heinrich Maria Drosten is a German virologist whose research focus is on novel viruses (emergent viruses). During the COVID-19 pandemic, Drosten came to national prominence as an expert on the implications and actions required to combat the illness in Germany.

Pandemic prevention is the organization and management of preventive measures against pandemics. Those include measures to reduce causes of new infectious diseases and measures to prevent outbreaks and epidemics from becoming pandemics.

Plandemic is a trilogy of conspiracy theory films produced by Mikki Willis promoting misinformation about the COVID-19 pandemic. They feature Judy Mikovits, a discredited American researcher and prominent anti-vaccine activist. The first video, Plandemic: The Hidden Agenda Behind Covid-19, was released on May 4, 2020, under Willis' production company Elevate Films. The second film, Plandemic Indoctornation, which includes more interviewees, was released on August 18 by Brian Rose's distributor of conspiracy theory related films, London Real. Later on June 3, 2023, Plandemic 3: The Great Awakening was released on The Highwire, a website devoted to conspiracy theories run by anti-vaccine activist Del Bigtree.

Seema Yasmin is a British-American physician, writer and science communicator based at Stanford University. She is Director of Research and Education at the Stanford Health Communication Initiative. During the COVID-19 pandemic, Yasmin helped to debunk myths about the coronavirus.

Nita Madhav is an epidemiologist and risk modeler who was CEO of Metabiota from 2019 - 2022.

Gary P. Kobinger is a Canadian immunologist and virologist who is currently the director at the Galveston National Laboratory at the University of Texas. He has held previous professorships at Université Laval, the University of Manitoba, and the University of Pennsylvania. Additionally, he was the chief of the Special Pathogens Unit at the National Microbiology Laboratory (NML) of the Public Health Agency of Canada (PHAC) in Winnipeg, Manitoba, for eight years. Kobinger is known for his critical role in the development of both an effective Ebola vaccine and treatment. His work focuses on the development and evaluation of new vaccine platforms and immunological treatments against emerging and re-emerging viruses that are dangerous to human health.

References

  1. Langreth, Robert. Finding the Next Epidemic Before It Kills. Forbes. 2 November 2009.
  2. 1 2 Geographic, National (June 2020). "Grantee 2004-2005: Nathan D. Wolfe". National Geographic Emerging Explorers. Retrieved 9 July 2020.
  3. Dwyer, Paul (December 24, 2020). "World-renowned virologist warned in 2008 about future epidemics". CNN. Retrieved January 3, 2021.
  4. Nathan Wolfe (2011), The Viral Storm: The Dawn of a New Pandemic Age, Henry Holt & Co.
  5. 1 2 "Nathan Wolfe". DCP3. Archived from the original on 29 June 2020. Retrieved 29 June 2020.
  6. Ratliff, Evan (July–August 2020). "We Can Protect the Economy From Pandemics. Why Didn't We?". Wired. Retrieved 9 July 2020.
  7. "Nathan Daniel Wolfe". Stanford University. Retrieved 29 June 2020.